Funding transnational collaborative research through joint transnational calls is one of the major objectives of E-Rare. This is the most important and effective joint activity to enhance the cooperation between European scientists working on rare diseases and thus reducing the fragmentation of research in this field. E-Rare launches calls on a yearly basis. The topic and eligibility criteria are specified every year and therefore may vary from one call to the other.

Austria
France
Germany
The Netherlands
Turkey
EMINA
European Multidisciplinary Initiative on Neuroacanthocytosis

Project Coordinator

Ludwig-Maximilians University Munich Klinikum Grosshadern Department of Neurology
Munich
Germany

Partners

François Tison Centre Hospitalier Universitaire de Bordeaux Service Neurologie Pessac, France
Giel Bosman Radboud University Medical Center Biochemistry Nijmegen, The Netherlands
Ody Sibon University Medical Center Groningen (UMCG) Cell Biology, Radiation and Stress Cell Biology Groningen, The Netherlands
Reiner Prohaska Medical University of Vienna Max F. Perutz Laboratories Vienna, Austria
Zuhal Yapici Istanbul Faculty of Medicine Department of Neurology Istanbul, Turkey

Neuroacanthocytosis (NA) syndromes are a group of rare disabling movement disorders displaying neurodegeneration and misshaped, spiky red blood cells (acanthocytes). EMINA is designed to mobilize and enable clinicians as well as basic scientists • to study the clinical aspects of NA syndromes and the effect of innovative treatment options • to discover the enigmatic connection between malformed red blood cells and neurodegeneration. The main goals of EMINA are to: • generate a common taxonomy of these heterogeneous diseases, • establish consensus guidelines for diagnosis and treatment and • reveal major pathophysiological mechanisms leading to disease and affecting both, erythrocytes and neurons. Because EMINA partners are already major contributors at the leading edge of NA research, the combination of their proven excellence in the fields of neurodegeneration, cell biology and animal models strengthens the prospects of important advances in this understudied field.

E-Rare 2012 - Created by Toussaint Biger